MedTrace Logo

Comparing the Perioperative Analgesic Effect of Two Different Volumes of Local Anesthetic Solution in Erector Spinae Plane Block in Patients Undergoing Modified Radical Mastectomy

NCT05813158 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2023-05-03

No results posted yet for this study

Summary

The aim of this study is to compare and evaluate the analgesic effects of ultrasound-guided Erector Spinae Plane block using low volumes and high concentrations versus high volumes and low concentrations in patients undergoing MRM.

Conditions

  • Comparing of 2 Different Volumes in ESPB in Patients Undergoing MRM

Interventions

DRUG

Group 1(low concentration-high volume bupivacaine US guided Erector Spinae Plane block)

Patients will preoperatively receive low concentration-high volume ultasound guided Erector Spinae Plane block, and then the patient will be transferred to the operating room ) one syringe of 30ml bupivacaine 0.25% {15 ml bupivacaine 0.5% and 15ml normal saline} for each patient

DRUG

Group 2(high concentration-low volumecbupivacaine US guided Erector Spinae Plane block)

Patients will preoperatively receive high concentration-low volume ultasound guided Erector Spinae Plane block, and then the patient will be transferred to the operating room (one syringe of 15 ml bupivacaine 0.5% {15 ml bupivacaine 0.5% } for each patien).

Sponsors & Collaborators

  • Yasmina sayed Abdrabo Ismael

    collaborator UNKNOWN

  • Norhan Abdelaleem Ali

    collaborator UNKNOWN

  • Ahmed Shaker Ragab

    collaborator UNKNOWN

  • Cairo University

    lead OTHER

Principal Investigators

  • Ahmed Abdalla Mohamed, M.D · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-09
Primary Completion
2022-12-16
Completion
2022-12-23

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05813158 on ClinicalTrials.gov